Here, we successfully constructed a unilateral ureteral obstruction (UUO) renal fibrosis model, identified the key differentially expressed genes using high-throughput mRNA sequencing, and then combined the key differential genes and CMap database to predict a potential drug (MK-2206, an Akt inhibitor) targeting renal fibrosis. Here, AKT1 is linked to renal fibrosis.